This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2009 by University Hospital, Geneva.
Recruitment status was:  Recruiting
Information provided by:
University Hospital, Geneva Identifier:
First received: May 19, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted


Single port access surgery is a rapidly progressing surgical approach which allows performance of standard laparoscopic surgery through a single transparietal port instead of multiple port accesses.


Demonstrate the validity of Single port access (SPA) cholecystectomy compared to multiple ports laparoscopic cholecystectomy.


SPA cholecystectomy is associated with decreased parietal and body image trauma compare to multiple ports laparoscopic cholecystectomy. SPA cholecystectomy should be associated with better cosmetic results, may improve postoperative recovery due to lower parietal pain. SPA cholecystectomy may also be associated with decreased rate of parietal complications as lower numbers of transparietal port are placed.


All patients offered cholecystectomy, either SPA or multiport cholecystectomy, included in the study will have recognized biliary pathology for which formal indication cholecystectomy are recognized internationally.

Surgical technique, either for SPA cholecystectomy or for multiple ports cholecystectomy, will be the same except, that one surgical technique is achieved through a single transparietal port and the other through multiple ports.

Randomization will be performed before surgeries after patients have given their informed consent to the study.

No specific test or cost will be necessitated by the study. Patients will be informed orally and will receive a short study summary, allowing them to give an informed consent.


  • Morbidity
  • Body image and Cosmetic results
  • Post-operative pain (opioid sparing effect)
  • Operative time
  • Hospital stay

Condition Intervention Phase
Symptomatic Gallbladder Stones Cholecystitis Biliary Pancreatitis Procedure: SPA cholecystectomy Procedure: Laparoscopic cholecystectomy Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Single Port Access Cholecystectomy Versus Standard Laparoscopic Cholecystectomy - Randomized Study

Resource links provided by NLM:

Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • Cosmesis, body image and quality of life scale [ Time Frame: at 1 month ]

Secondary Outcome Measures:
  • Post-operative morbidity [ Time Frame: at 30 days ]
  • Post-operative pain [ Time Frame: 10 days ]
  • Operative time [ Time Frame: day 1 ]

Estimated Enrollment: 200
Study Start Date: February 2009
Estimated Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
SPA cholecystectomy
Procedure: SPA cholecystectomy
SPA cholecystectomy
laparoscopic cholecystectomy
Procedure: Laparoscopic cholecystectomy
Laparoscopic cholecystectomy


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age more than 18 years

Exclusion Criteria:

  • Contraindication to laparoscopy
  • Liver disease
  • Cognitive trouble
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00904865

Contact: Pascal Bucher, MD +41223723311 ext 7958420

University Hospital Geneva Recruiting
Geneva, Switzerland, 1211
Contact: Pascal Bucher, MD    ¦41223723311 ext 7958420   
Principal Investigator: Pascal Bucher, MD         
Sponsors and Collaborators
University Hospital, Geneva
Principal Investigator: Pascal Bucher, MD University Hospital, Geneva
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Bucher Pascal, MD, University Hospital Geneva Identifier: NCT00904865     History of Changes
Other Study ID Numbers: CER-08-145
Study First Received: May 19, 2009
Last Updated: May 19, 2009

Keywords provided by University Hospital, Geneva:
Single port access

Additional relevant MeSH terms:
Acalculous Cholecystitis
Pancreatic Diseases
Digestive System Diseases
Gallbladder Diseases
Biliary Tract Diseases
Pathological Conditions, Anatomical processed this record on August 21, 2017